Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Budyak IL"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Budyak IL; Biopharmaceutical Research and Development, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, United States. Electronic address: budyak_ivan_l@lilly.com., Huang L; Biopharmaceutical Research and Development, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, United States., Dukor RK; BioTools Inc., Jupiter, FL 33478, United States.
Publikováno v:
Journal of pharmaceutical sciences [J Pharm Sci] 2024 Aug; Vol. 113 (8), pp. 2651-2655. Date of Electronic Publication: 2024 May 14.
Autor:
Saggu M; Pharmaceutical Development, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA. Electronic address: saggu.miguel@gene.com., Bou-Assaf GM; Analytical Development, Biogen, Cambridge, Massachusetts, USA., Bucher R; Product Development Safety, Clinical Safety, F. Hoffmann-La Roche, Basel, Switzerland., Budyak IL; Biopharmaceutical Research and Development, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, USA., Buecheler J; Technical Research and Development, Novartis Pharma AG, 4002 Basel, Switzerland., Cao S; Process Development, Amgen Inc., 1 Amgen Center Drive, Thousand Oaks, CA 91320, USA., Groenning M; CMC Biophysical Analysis, Novo Nordisk A/S, Novo Nordisk Park, Måløv, Denmark., Khan E; Late Respiratory and Immunology, AstraZeneca, Academy House, Cambridge, UK., Kwok SC; Dosage Form Design & Development, BioPharmaceuticals Development, AstraZeneca, One Medimmune Way, Gaithersburg, Maryland 20878, USA., Minocha S; Injectable Drug Product Development, Alexion, AstraZeneca Rare Disease, 121 Seaport Blvd, Boston, Massachusetts, USA., Pisupati K; Biopharmaceutical Research and Development, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, USA., Radhakrishnan V; Injectable Drug Product Development, Alexion, AstraZeneca Rare Disease, 121 Seaport Blvd, Boston, Massachusetts, USA., Videbæk N; Clinical Immunogenicity Analysis, Novo Nordisk A/S, Novo Nordisk Park, Måløv, Denmark., Yang DT; Biopharmaceutical Research and Development, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, USA., Zhang B; Injectable Drug Product Development, Alexion, AstraZeneca Rare Disease, 121 Seaport Blvd, Boston, Massachusetts, USA., Narhi LO; BioPhia Consulting, USA. Electronic address: lnarhi@BioPhia.com.
Publikováno v:
Journal of pharmaceutical sciences [J Pharm Sci] 2024 May; Vol. 113 (5), pp. 1401-1414. Date of Electronic Publication: 2024 Jan 12.
Autor:
Yang J; Department of Chemical and Biomolecular Engineering, University of Notre Dame, Notre Dame, Indiana 46556, United States., Ostafe R; Molecular Evolution, Protein Engineering and Production Facility, Purdue Institute for Inflammation, Immunology and Infection Diseases, Purdue University, West Lafayette, Indiana 47907, United States., Welch CJ; Indiana Consortium for Analytical Science & Engineering (ICASE), 410 W. 10th St., # 1020H, Indianapolis, Indiana 46202, United States., Verhalen B; Corteva Agriscience, 8325 NW 62nd Ave, Johnston, Iowa 50131, United States., Budyak IL; Biopharmaceutical Research and Development, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, United States., Bruening ML; Department of Chemical and Biomolecular Engineering, University of Notre Dame, Notre Dame, Indiana 46556, United States.; Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana 46556, United States.
Publikováno v:
Analytical chemistry [Anal Chem] 2023 Jun 06; Vol. 95 (22), pp. 8541-8551. Date of Electronic Publication: 2023 May 22.
Autor:
Shahfar H; Department of Chemical and Biomolecular Engineering, University of Delaware, Newark, Delaware19716, United States., O'Brien CJ; Department of Chemical and Biomolecular Engineering, University of Delaware, Newark, Delaware19716, United States., Budyak IL; Bioproduct Research and Development, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana46285, United States., Roberts CJ; Department of Chemical and Biomolecular Engineering, University of Delaware, Newark, Delaware19716, United States.
Publikováno v:
Molecular pharmaceutics [Mol Pharm] 2022 Nov 07; Vol. 19 (11), pp. 3820-3830. Date of Electronic Publication: 2022 Oct 04.
Autor:
Bou-Assaf GM; Analytical Development, Biogen, 225 Binney St., Cambridge, MA 02142., Budyak IL; Bioproduct Research and Development, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA., Brenowitz M; Departments of Biochemistry and Molecular Pharmacology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461., Day ES; Pharmaceutical Development, Genentech a Member of the Roche Group, 1 DNA Way, South San Francisco, CA 94080., Hayes D; IntlSoSci, 23 Washington St., Gorham, NH 03581., Hill J; Department of Bioengineering, University of Washington, Seattle, WA 98105., Majumdar R; Bioproduct Research and Development, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA., Ringhieri P; Analytical Development Biotech Department, Merck Serono S.p.a, Guidonia, RM, Italy; an affiliate of Merck KGaA., Schuck P; Laboratory of Dynamics of Macromolecular Assembly, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, 13 South Drive, Bethesda, MD 20892., Lin JC; Pharmaceutical Development, Genentech a Member of the Roche Group, 1 DNA Way, South San Francisco, CA 94080. Electronic address: lin.jasper@gene.com.
Publikováno v:
Journal of pharmaceutical sciences [J Pharm Sci] 2022 Jul; Vol. 111 (7), pp. 2121-2133. Date of Electronic Publication: 2022 Jan 02.
Autor:
Scannell MJ; Department of Chemistry and Biochemistry, University of North Carolina Wilmington, 601 S. College Road, Wilmington, NC, 28403, USA., Hyatt MW; Lilly Research Laboratories, Bioproduct Research and Development, Eli Lilly and Company, Indianapolis, IN, 46285, USA., Budyak IL; Lilly Research Laboratories, Bioproduct Research and Development, Eli Lilly and Company, Indianapolis, IN, 46285, USA., Woldeyes MA; Lilly Research Laboratories, Bioproduct Research and Development, Eli Lilly and Company, Indianapolis, IN, 46285, USA. woldeyes_mahlet@lilly.com., Wang Y; Department of Chemistry and Biochemistry, University of North Carolina Wilmington, 601 S. College Road, Wilmington, NC, 28403, USA. wangyy@uncw.edu.
Publikováno v:
Pharmaceutical research [Pharm Res] 2021 Nov; Vol. 38 (11), pp. 1947-1960. Date of Electronic Publication: 2021 Oct 13.
Autor:
Doyle BL; Bioproduct Research and Development, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, 46285, USA., Rauk AP; Global Statistical Sciences, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, 46285, USA., Weiss WF 4th; Bioproduct Research and Development, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, 46285, USA., Budyak IL; Bioproduct Research and Development, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, 46285, USA. Electronic address: budyak_ivan_l@lilly.com.
Publikováno v:
Analytical biochemistry [Anal Biochem] 2020 Sep 15; Vol. 605, pp. 113837. Date of Electronic Publication: 2020 Jul 20.
Autor:
Doyle BL; Biopharmaceutical Research and Development, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA., Budyak IL; Biopharmaceutical Research and Development, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA., Rauk AP; Global Statistical Sciences, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA., Weiss WF 4th; Biopharmaceutical Research and Development, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA. Electronic address: weisswf@lilly.com.
Publikováno v:
Analytical biochemistry [Anal Biochem] 2017 Aug 15; Vol. 531, pp. 16-19. Date of Electronic Publication: 2017 May 19.
Autor:
Budyak IL; Biopharmaceutical Research and Development, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA., Griffiths KL; Global Statistical Sciences, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA., Weiss WF 4th; Biopharmaceutical Research and Development, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA. Electronic address: weisswf@lilly.com.
Publikováno v:
Analytical biochemistry [Anal Biochem] 2016 Nov 15; Vol. 513, pp. 36-38. Date of Electronic Publication: 2016 Aug 24.